Responses
Emerging technologies, pharmacology and therapeutics
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline
Compose a Response to This Article
Other responses
No responses have been published for this article.